Journal of the Neurological Sciences
Volume 264, Issue 1 , Pages 43-49 , 15 January 2008

Cerebral small vessel disease and C-reactive protein: Results of a cross-sectional study in community-based Japanese elderly

Received 9 March 2007 ,Revised 23 June 2007 ,Accepted 28 June 2007.

References 

  1. Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, Massaro JM, et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke. 2001;32:2575–2579
  2. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115–126
  3. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analysis. BMJ. 2000;321:199–204
  4. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836–843
  5. Sakkinen P, Abbott RD, Curb JD, Rodriguez BL, Yano K, Tracy RP. C-reactive protein and myocardial infarction. J Clin Epidemiol. 2002;55:445–451
  6. Albert MA, Glynn RJ, Buring J, Ridker PM. C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am J Cardiol. 2004;93:1238–1242
  7. Khera A, McGuire DK, Murphy SA, Stanek HG, Das SR, Vongpatanasin W, et al. Race and gender differences in C-reactive protein levels. J Am Coll Cardiol. 2005;46:464–469
  8. Ichikawa K, Itoh Y, Min WK, Yap SF, Lam CW, Kong XT, et al. Diagnosis and epidemiological implication of regional differences in serum concentrations of proteins observed in six Asian cities. Clin Chem Lab Med. 2004;42:800–809
  9. Saito I, Folsom AR, Aono H, Ozawa H, Ikeda T, Yamashita T. Comparison of fatal coronary heart disease occurrence based on population surveys in Japan and the USA. Int J Epidemiol. 2000;29:837–844
  10. Schillinger M, Exner M, Mlekusch W, Sabeti S, Amighi J, Nikowitsch R, et al. Inflammation and Carotid Artery-Risk for Atherosclerosis Study (ICARAS). Circulation. 2005;111:2203–2209
  11. Alvarez Garcia B, Ruiz C, Chacon P, Sabin JA, Matas M. High-sensitivity C-reactive protein in high-grade carotid stenosis: risk marker for unstable carotid plaque. J Vasc Surg. 2003;38:1018–1024
  12. Schmidt R, Schmidt H, Pichler M, Enzinger C, Petrovic K, Niederkorn K, et al. C-reactive protein, carotid atherosclerosis, and cerebral small-vessel disease: results of the Austrian Stroke Prevention Study. Stroke. 2006;37:2910–2916
  13. Van Dijik E, Prins N, Vermeer S, Vrooman H, Hofman A, Koudstaal P, et al. C-reactive protein and cerebral small vessel disease: the Rotterdam Scan Study. Circulation. 2005;112:900–905
  14. O'Brien JT, Erkinjunitti T, Reisberg B, Roman G, Sawada T, Pantoni L, et al. Vascular cognitive impairment. Lancet Neurol. 2003;2:89–98
  15. Vermeer SE, Hollander M, Van Dijik EJ, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke. 2003;34:1126–1129
  16. Khreiss T, Jozsef L, Potempa LA, Filep JG. Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells. Circulation. 2004;109:2016–2022
  17. Wada M, Nagasawa H, Kurita K, Koyama S, Arawaka S, Kawanami T, et al. Microalbuminuria is a risk factor for cerebral small vessel disease in community-based elderly subjects. J Neurol Sci. 2007;255:27–34
  18. Alberti KG, Zimmet PZ. Definition, diagnosis, and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–553
  19. Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology. 1993;43:1683–1689
  20. Mannami T, Konishi M, Baba S, Nishi N, Terao A. Prevalence of asymptomatic carotid atherosclerotic lesions detected by high-resolution ultrasonography and its relation to cardiovascular risk factors in the general population of a Japanese city: the Suita study. Stroke. 1997;28:518–525
  21. Ridker PM, Rifai N, Pfeffer M, Sacks F, Moye LA, Goldman S, et al. Cholesterol and Recurrent Events (CARE) Investigators. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Circulation. 1998;98:839–844
  22. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, et al. Markers of inflammation and cardiovascular disease : application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499–511
  23. Saito I, Sato S, Nakamura M, Kokubo Y, Mannami T, Adachi H, et al. A low level of C-reactive protein in Japanese adults and its association with cardiovascular risk factors: the Japan NCVC-collaborative Inflammation Cohort (JNIC) study. Atherosclerosis in press, doi:10.1016/j.atherosclerosis.2006.07.032.
  24. Pantoni L, Lammie A. Cerebral small vessel disease: pathological and pathophysiological aspects in relation to vascular cognitive impairment. In:  Erkinjunitti T,  Gauthier S editor. Vascular cognitive impairment. London: Martin Dunitz Ltd; 2002;p. 115–133

PII: S0022-510X(07)00485-6

doi: 10.1016/j.jns.2007.06.053

Journal of the Neurological Sciences
Volume 264, Issue 1 , Pages 43-49 , 15 January 2008

Article Tools